Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry-Reference-Cited by-同舟云学术

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER Registry

Published:2009-10 Issue:4 Volume:158 Page:569-575
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Rakowski Tomasz,Siudak Zbigniew,Dziewierz Artur,Birkemeyer Ralf,Legutko Jacek,Mielecki Waldemar,Depukat Rafal,Janzon Magnus,Stefaniak Justyna,Zmudka Krzysztof,Dubiel Jacek S.,Partyka Lukasz,Dudek Dariusz

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

2. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology;Van de Werf;Eur Heart J,2008

3. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials;De Luca;JAMA,2005

4. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up;Montalescot;Eur Heart J,2007

5. Comparison of angioplasty with stenting, with or without abciximab in acute myocardial infarction;Stone;N Engl J Med,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Treatment of ST-Segment–Elevation Myocardial Infarction Patients With Ticagrelor or Other P2Y 12 Inhibitors Before Primary Percutaneous Coronary Intervention a Strategy Without Benefit?;Circulation: Cardiovascular Interventions;2018-03

3. Astronauts, meteors and the known universe of antithrombotic therapies used in primary angioplasty;G ITAL CARDIOL;2017

4. Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of Emergency Medicine (SIMEU) and Italian Society of Interventional Cardiology (SICI-GISE);European Heart Journal Supplements;2017-05

5. ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome;European Heart Journal Supplements;2014-11-28